Related Experiment Video
Updated: Feb 3, 2026

The Mouse Stroke Unit Protocol with Standardized Neurological Scoring for Translational Mouse Stroke Studies
Published on: February 7, 2025
Serotonin Selective Reuptake Inhibitors (SSRIs) and Stroke
F Chollet1,2, J Rigal3,4, P Marque4,5
1Neurology Department, Hôpital Pierre-Paul Riquet, Centre Hospitalier Universitaire de Toulouse, Toulouse, France. fchperso@gmail.com.
Purpose Of Review:
The interest in SSRIs after stroke has increased in the past few years, with better knowledge of post-stroke depression and with the demonstrated capacity of some SSRIs to act on the functional recovery of non-depressed subjects.
Recent Findings:
Arguments for the action of SSRIs in favour of post-stroke neurological function recovery have improved through new elements: basic science and preclinical data, positive clinical trials and repeated series of stroke patient meta-analysis, and confirmation of favourable safety conditions in post-stroke patients. Global coherence is appearing, showing that SSRIs improve stroke recovery in non-depressed patients when given for 3 months after the stroke, with highly favourable safety conditions and a favourable benefit/risk ratio. Large series are still needed.
Related Concept Videos
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
What is Natural Selection?
Antibiotic Selection
Types of Selection

